The 5-HT 3 receptor is a prototypical member of the Cys-loop ligand-gated ion channel (LGIC) superfamily and an established therapeutic target. In addition to activation via the orthosteric site, receptor function can be modulated by allosteric ligands. We have investigated the pharmacological action of Cl-indole upon the 5-HT 3 A receptor and identified that this positive allosteric modulator possesses a novel mechanism of action for LGICs.
EXPERIMENTAL APPROACHThe impact of Cl-indole upon the 5-HT 3 receptor was assessed using single cell electrophysiological recordings and [ 3 H]-granisetron binding in HEK293 cells stably expressing the 5-HT 3 receptor.
KEY RESULTSCl-indole failed to evoke 5-HT 3 A receptor-mediated responses (up to 30 μM) or display affinity for the [ 3 H]-granisetron binding site. However, in the presence of Cl-indole, termination of 5-HT application revealed tail currents mediated via the 5-HT 3 A receptor that were independent of the preceding 5-HT concentration but were antagonized by the 5-HT 3 receptor antagonist, ondansetron. These tail currents were absent in the 5-HT 3 AB receptor. Furthermore, the presence of 5-HT revealed a concentration-dependent increase in the affinity of Cl-indole for the orthosteric binding site of the human 5-HT 3 A receptor.
CONCLUSIONS AND IMPLICATIONSCl-indole acts as both an orthosteric agonist and an allosteric modulator, but the presence of an orthosteric agonist (e.g. 5-HT) is a prerequisite to reveal both actions. Precedent for ago-allosteric action is available, yet the essential additional presence of an orthosteric agonist is now reported for the first time. This widening of the pharmacological mechanisms to modulate LGICs may offer further therapeutic opportunities.
IntroductionThe 5-HT 3 receptor is an excitatory ligand-gated ion channel (LGIC) of the Cys-loop family that includes the nicotinic ACh receptors (nAChR), glycine and GABA A receptors, and Zn 2+ -activated receptors (Barnes et al., 2009;daCosta and Baenziger, 2013). Members of this LGIC family share a common pentameric structure, an observation recently confirmed by the publication of the X-ray structure of the mouse 5-HT 3 A receptor (Hassaine et al., 2014). Each subunit of the 5-HT 3 receptor is composed of an extracellular N-terminal domain, four transmembrane domains and a short extracellular C-terminal domain. The orthosteric binding site is located at the interface between two adjacent N-terminal domains (daCosta and Baenziger, 2013).Five human 5-HT 3 receptor subunits have been identified (5-HT3A to 5-HT3E) (Karnovsky et al., 2003;Niesler et al., 2003). The native receptor can exist as a simple homopentamer of 5-HT3A subunits or heteropentamers containing the 5-HT3A subunit and at least one other of the 5-HT3B to E subunits (Niesler, 2011). The pentameric structure gives rise to a potential for five ligand binding sites, but recent evidence suggests that just two or three sites are occupied for maximal activation of the channel (Corradi et al., 2009). Studies using heteromeric...